[1] Wicha MS.Cancer stem cells and metastasis:lethal seeds[J].Clin Cancer res,2006,12(19):5606-5607.
[2] Li H,Tang DG.Prostate cancer stem cells and their potential roles in metastasis[J].J Surq Oncol,2011,103(6):585-562.
[3] 邹维艳,王俊斌,严海芹,等.癌干细胞标记物 CD44 与 ESA在舌癌淋巴道转移模型中的表达及其意义[J].中国免疫学杂志,2012,28(2):122-125.
[4] Kim M,Tumquist H,Jackson J,et al.The multidrug resistance transporter ABCG2(breast cancer resistance protein 1)effluxes Hoechst 33342 and is overexpressed in hematopoietic stem cells[J].Clin Cancer res,2002,8(1):22-28.
[5] Zhou S,Schuetz JD,Bunting KD,et al.The ABC transporter Bcrp1/ABCG2 is expressed in a wide variety of stem cells and is a molecular determinant of the side-population phenotype[J].Nat Med,2001,7(9):1028-1034.
[6] 蔡捷,姚金光,黄英华,等.舌癌淋巴道转移模型中分离并建 立舌癌细胞永生化细胞系[J].广西医科大学学报,2009,26(4):500-502.
[7] Singh SK,Clarke ID,Terasaki M,et al.Identification of a cancer stem cell in human brain tumors[J].Cancer res,2003 63(18):5821-5828.
[8] Hermann PC,Huber SL,Herrler T,et al.Distinct populations of cancer stem cells determined tumor growth and metastatic activity in human pancreatic cancer[J].Cell Stem Cell,2007,1(3):313-323.
[9] Prince ME,Sivanandan r,Kaczorowski A,et al.Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma[J].Proc Natl Acad Sci USA,2007,104(3):973-978.
[10] Dalerba P,Dylla SJ,Park IK,et al.Phenotypic characterization of human colorectal cancer stem cells[J].Proc Natl Acad Sci USA,2007,104(24):10158-10163.
[11] Zhang M,Song T,Yang L,et al.Nestin and CD133:valuable stem cell-specific markers for determining clinical outcome of glioma patients[J].J Exp Clin Cancer res,2008,27:85.
[12] Al-Hajj M,Wicha MS,Benito-Hernandez A,et al.Prospective identification of tumorigenic breast cancer cells[J].Proc Natl Acad Sci USA,2003,100(7):3983-3988.
[13] ricci-Vitiani L,Lombardi DG,Pilozzi E,et al.Identification and expansion of human colon-cancer-initiating cells[J].Nature,2007,445(7123):111-115.
[14] O'Brien CA,Pollett A,Gallinger S,et al.A human colon cancer capable of initiating tumour growth in immunodeficient mice[J].Nature,2007,445(7):106-110.
[15] Du L,Wang H,He L,et al.CD44 is of functional importance for colorectal cancer stem cells[J].Clin Cancer res,2008,14(21):6751-6760.
[16] Horst D,Krieql L,Engel J,et al.Prognostic significance of the cancer stem cell markers CD133,CD44,and CD166 in colorectal cancer[J].Cancer Invest,2009,27(8):844-850.
[17] Adamia S,Maxwell CA,Pilarski LM.Hyaluronan and hyaluronan synthases:potential therapeutic targets in cancer[J].Curr Drug Targets Cardiovasc Haematol Disord,2005,5(1):3-14.
[18] Horst D,Scheel SK,Liebmann S,et al.The cancer stem cell marker CD133 has high prognostic impact but unknown functional relevance for the metastasis of human colon cancer[J].JPathol,2009,219(4):427-434.
[19] Calcagno AM,Fostel JM,To KK,et al.Single-step doxorubicin-selected cancer cells overexpress the ABCG2 drug transporter through epigenetic changes[J].Br J Cancer,2008,98(9):1515-1524.
[20] Lagas JS,van der Kruijssen CM,van de Wetering K,et al.Transport of diclofenac by breast cancer resistance protein(ABCG2)and stimulation of multidrug resistance protein 2(ABCC2)-mediated drug transport by diclofenac and benzbromarone[J].Drug Metab Dispos,2009,37(1):129-136.
[21] Lou H,Dean M.Targeted therapy for cancer stem cells:the patched pathway and ABC transporters[J].Oncogene,2007,26(9):1357-1360.
[22] Lv H,He Z,Liu X,et al.reversal of BCrP-mediated multidrug resistance by stable expression of small interfering rNAs[J].J Cell Biochem,2007,102(1):75-81.